Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 441-447

  Xu, Hua ^a   Mao, Shan Hua ^a   Ding, Guan Xiong ^a   Ding, Qiang ^a   Jiang, Hao Wen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Meta analysis; Prostate cancer

Indexed keywords

EID: 84877117305     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.441     Document Type: Article

References (63)

1. Abdollah F, Briganti A, Suardi N, et al (2011). Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis, 14, 74-8.
2. Aschebrook-Kilfoy B, Sabra MM, Brenner A, et al (2011). Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid, 21, 957-63.
3. Baillargeon J, Pollock BH, Kristal AR, et al (2005). The association of body mass index and prostate-specific antigen in a population-based study. Cancer, 103, 1092-5.
4. Baradaran N, Ahmadi H, Salem S, et al (2009). The protective effect of diabetes mellitus against prostate cancer: role of sex hormones. Prostate, 69, 1744-50.
5. Ben Q, Xu M, Ning X, et al (2011). Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer, 47, 1928-37.
6. Bonovas S, Filioussi K, Tsantes A (2004). Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia, 47, 1071-8.
7. Calton BA, Chang SC, Wright ME, et al (2007). History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control, 18, 493-503.
8. Chan JM, Latini DM, Cowan J, et al (2005). History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control, 16, 789-97.
9. Checkoway H, DiFerdinando G, Hulka BS, Mickey DD (1987). Medical, life-style, and occupational risk factors for prostate cancer. Prostate, 10, 79-88.
10. Coker AL, Sanderson M, Zheng W, Fadden MK (2004). Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br J Cancer, 90, 2171-5.
11. Coughlin SS, Neaton JD, Sengupta A (1996). Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol, 143, 1002-6.
12. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
13. Freedland SJ, Platz EA, Presti JC, Jr., et al (2006). Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol, 175, 500-4; discussion 4.
14. Gallus S, Foschi R, Talamini R, et al (2007). Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy. Urology, 70, 1121-6.
15. Giovannucci E, Rimm EB, Stampfer MJ, et al (1998). Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control, 9, 3-9.
16. Gong Z, Neuhouser ML, Goodman PJ, et al (2006). Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev, 15, 1977-83.
17. Gonzalez-Perez A, Garcia Rodriguez LA (2005). Prostate cancer risk among men with diabetes mellitus (Spain). Cancer Causes Control, 16, 1055-8.
18. Greenland S, Longnecker MP (1992). Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol, 135, 1301-9.
19. Grundmark B, Garmo H, Loda M, et al (2010). The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev, 19, 2088-96.
20. Gunnell D, Oliver SE, Peters TJ, et al (2003). Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer, 88, 1682-6.
21. Higgins JP, Thompson SG, Deeks JJ, and Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
22. Jiang X, Bernstein L, Tseng CC, Wu AH (2012). Diabetes and risk of esophageal and gastric adenocarcinomas. Int J Cancer, 131, 1417-22.
23. Jin T (2008). Why diabetes patients are more prone to the development of colon cancer? Med Hypotheses, 71, 241-4.
24. Joh HK, Willett WC, Cho E (2011). Type 2 diabetes and the risk of renal cell cancer in women. Diabetes Care, 34, 1552-6.
25. Kasper JS, Giovannucci E (2006). A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 2056-62.
26. Kasper JS, Liu Y, Giovannucci E (2009). Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer, 124, 1398-403.
27. La Vecchia C, Negri E, Franceschi S, et al (1994). A case-control study of diabetes mellitus and cancer risk. Br J Cancer, 70, 950-3.
28. Laukkanen JA, Laaksonen DE, Niskanen L, et al (2004). Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev, 13, 1646-50.
29. Lee MS, Hsu CC, Wahlqvist ML, et al (2011). Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer, 11, 20.
30. Lee MY, Lin KD, Hsiao PJ, Shin SJ (2012). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.
31. Leitzmann MF, Ahn J, Albanes D, et al (2008). Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control, 19, 1267-76.
32. Li Q, Kuriyama S, Kakizaki M, et al (2010). History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study. Cancer Causes Control, 21, 1025-32.
33. Lightfoot N, Conlon M, Kreiger N, et al (2004). Medical history, sexual, and maturational factors and prostate cancer risk. Ann Epidemiol, 14, 655-62.
34. MacInnis RJ, English DR (2006). Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control, 17, 989-1003.
35. Mishina T, Watanabe H, Araki H, Nakao M (1985). Epidemiological study of prostatic cancer by matched-pair analysis. Prostate, 6, 423-36.
36. Mitin T, Chen MH, Zhang Y, et al (2011). Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy. J Urol, 186, 2233-7.
37. Moreira DM, Anderson T, Gerber L, et al (2011). The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes Control, 22, 977-83.
38. Pater LE, Hart KW, Blonigen BJ, et al (2012). Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population. Am J Clin Oncol, 35, 490-2.
39. Pelucchi C, Serraino D, Negri E, et al (2011). The metabolic syndrome and risk of prostate cancer in Italy. Ann Epidemiol, 21, 835-41.
40. Pierce BL, Plymate S, Ostrander EA, Stanford JL (2008). Diabetes mellitus and prostate cancer risk. Prostate, 68, 1126-32.
41. Pourmand G, Salem S, Mehrsai A, et al (2007). The risk factors of prostate cancer: a multicentric case-control study in Iran. Asian Pac J Cancer Prev, 8, 422-8.
42. Ragozzino M, Melton LJ, 3rd, Chu CP, Palumbo PJ (1982). Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis, 35, 13-9.
43. Rodriguez C, Patel AV, Mondul AM, et al (2005). Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol, 161, 147-52.
44. Rosenberg DJ, Neugut AI, Ahsan H, Shea S (2002). Diabetes mellitus and the risk of prostate cancer. Cancer Invest, 20, 157-65.
45. Smith GD, Egger M, Shipley MJ, Marmot MG (1992). Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol, 136, 1110-4.
46. Steenland K, Nowlin S, Palu S (1995). Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev, 4, 807-11.
47. Tavani A, Gallus S, Bertuzzi M, et al (2005). Diabetes mellitus and the risk of prostate cancer in Italy. Eur Urol, 47, 313-7; discussion 7.
48. Tavani A, Gallus S, Bosetti C, et al (2002). Diabetes and the risk of prostate cancer. Eur J Cancer Prev, 11, 125-8.
49. Thompson MM, Garland C, Barrett-Connor E, et al (1989). Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol, 129, 511-7.
50. Tseng CH (2011). Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care, 34, 616-21.
51. Turner EL, Lane JA, Donovan JL, et al (2011). Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study). Int J Cancer, 128, 440-6.
52. Velicer CM, Dublin S, White E (2007). Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications. Prostate Cancer Prostatic Dis, 10, 46-51.
53. Wallstrom P, Bjartell A, Gullberg B, et al (2009). A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer, 100, 1799-805.
54. Waters KM, Henderson BE, Stram DO, et al (2009). Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol, 169, 937-45.
55. Weiderpass E, Gridley G, Persson I, et al (1997). Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer, 71, 360-3.
56. Weiderpass E, Ye W, Vainio H, et al (2002). Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer, 102, 258-61.
57. Wideroff L, Gridley G, Mellemkjaer L, et al (1997). Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst, 89, 1360-5.
58. Will JC, Vinicor F, Calle EE (1999). Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology, 10, 313-8.
59. Woolf B (1955). On estimating the relation between blood group and disease. Ann Hum Genet, 19, 251-3.
60. Wright JL, Stanford JL (2009). Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control, 20, 1617-22.
61. Wynder EL, Mabuchi K, Whitmore WF, Jr. (1971). Epidemiology of cancer of the prostate. Cancer, 28, 344-60.
62. Zhu K, Lee IM, Sesso HD, et al (2004). History of diabetes mellitus and risk of prostate cancer in physicians. Am J Epidemiol, 159, 978-82.
63. Zimmet P, Alberti KG, Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature, 414, 782-7.